论文部分内容阅读
目的:观察中药痰热清注射液治疗社区获得性肺炎的疗效,主要研究该药的抗感染作用和退热作用,并观察其可能出现的不良反应;观察该药与氨溴索对比的治疗效果,探索中西药联用治疗社区获得性肺炎的新方法。方法:本试验采用随机对照法治疗社区获得性肺炎,观察组采用常规抗炎、化痰、止咳治疗,辅以痰热清注射液静脉滴注;对照组采用常规抗炎、止咳、化痰治疗,辅以氨溴索静脉滴注。结果:观察组总有效率为91,67%,对照组总有效率为76.67%,二者相比差异有统计学意义(P<0.05)。观察组治疗后血常规和C反应蛋白的降低明显优于治疗前;治疗后观察组血常规和C反应蛋白的降低明显优于对照组,均具有统计学意义。结论:痰热清注射液治疗社区获得性肺炎疗效较好,无不良反应,值得临床广泛应用。
OBJECTIVE: To observe the curative effect of Tanreqing Injection on community-acquired pneumonia, mainly to study its anti-infective and antipyretic effects and to observe its possible adverse reactions. To observe the therapeutic effect of this drug in combination with ambroxol , Explore the new method of Chinese and Western medicine combined treatment of community-acquired pneumonia. Methods: In this study, community-acquired pneumonia was treated by randomized controlled trial. The observation group was treated with routine anti-inflammatory, phlegm-resolving and cough-relieving therapy and intravenous infusion of Tanreqing Injection. The control group was treated with conventional anti-inflammatory, , Supplemented by intravenous infusion of ambroxol. Results: The total effective rate was 91.67% in the observation group and 76.67% in the control group, the difference was statistically significant (P <0.05). The reduction of blood routine and C-reactive protein in the observation group was better than that before treatment. The reduction of blood routine and C-reactive protein in the observation group was significantly better than that of the control group after treatment, both of which were statistically significant. Conclusion: Tanreqing injection for the treatment of community-acquired pneumonia is better, no adverse reactions, it is widely used in clinical.